Pioglitazone Hydrochloride CAS NO.112529-15-4

Send Inquiry
Pioglitazone Hydrochloride CAS NO.112529-15-4
Details
cell biology; hypoglycemic agents; bioactive small molecules; antipyretic analgesics; plant extracts; cell signaling and Neurobiology CGMP WC
Category
Pioglitazone API
Share to
Description

Pioglitazone Hydrochloride Basic information

Product Name:

Pioglitazone Hydrochloride

Synonyms:

Effects of pioglitazone;Pioglitazonehydrochloride;pioglitazonehydrochioride;Pioditazone hydrochloride;ACTOS;5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride;5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride;PIOGLITAZONE HCL;[5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride;AD-4833

CAS:

112529-15-4

MF:

C15H21N3O3S

MW:

392.9

Pioglitazone Hydrochloride Chemical Properties

Melting point

193-194°C

Boiling point 575.4ºC at 760 mmHg
Density 1.26 g/cm3

Appearance

White crystal or crystalline powder

Pioglitazone Hydrochloride Indications

Indications

Type 2 diabetes mellitus (NIDDM)

 

 

 

Pioglitazone hydrochloride is an oral antidiabetic drug of thiazolidinedione type. It is an agonist of highly selective peroxisome proliferator activated receptor gamma (PPAR γ). It can control blood glucose level by improving insulin sensitivity of peripheral and liver. Its main mechanism of action is to activate PPAR γ nuclear receptors in adipose tissue, skeletal muscle tissue and liver tissue, so as to regulate the transcription of insulin responsive genes and control the generation, transport and utilization of blood glucose.

 

Hot Tags: pioglitazone hydrochloride cas no.112529-15-4, China, manufacturers, suppliers, factory, custom, wholesale

Send Inquiry